Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation

Clinical trial NCT07397351 · RECRUITING

Trial details

NCT number: NCT07397351
Sponsor: Research Institute of Geroprotective Technologies
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2026-03-05
Primary completion: 2026-10-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.